Oslo, 18 October 2016
Weifa ASA (OSE: WEIFA), Norway's leading consumer health company, will release its third quarter 2016 results on Tuesday 25 October 2016.
The results will be presented by Weifa's CEO Kathrine Gamborg Andreassen and CFO Simen Nyberg-Hansen at 08:30 CET at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. Following the presentation, there will be a Q&A session. The presentation will be held in English.
The presentation will also be webcast live and can be accessed directly from http://webtv.hegnar.no/presentation.php?webcastId=40094288 or www.weifa.no/webcast . Questions may be submitted live during the presentation.
The quarterly report and the presentation materials will be available on www.weifa.no/investor/
and www.newsweb.no , as well as on news wires.
Weifa welcomes all interested parties.
For further information, please contact:
+47 98 20 63 55
Weifa is Norway's leading consumer health company. We supply real value through medicines, lifestyle products and solutions that address the essential needs of consumers, customers and professional partners. Weifa was founded in 1940 and now employs about 30 highly qualified people at our headquarters in Oslo. The company has a strong position in Norway and is the market leader in pain relief, with well-established brands such as Paracet and Ibux. We are also present in other key areas such as dietary supplements and treatment for colds and respiratory problems. Weifa is listed on the Oslo Børs (ticker WEIFA). For further information, please visit: www.weifa.no
Last updated on: 19/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.